[1] OKUYAN HM, COŞKUN A, BEGEN MA. Current status, opportunities, and challenges of exosomes in diagnosis and treatment of osteoarthritis. Life Sci. 2025;362:123365.
[2] PAN C, LU F, HAO X, et al. Low-intensity pulsed ultrasound delays the progression of osteoarthritis by regulating the YAP-RIPK1-NF-κB axis and influencing autophagy. J Transl Med. 2024;22(1):286.
[3] YAO Q, WU X, TAO C, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):56.
[4] MOHD NOOR NA, ABDULLAH NURUL A, AHMAD MOHD ZAIN MR, et al. Extracellular Vesicles from Mesenchymal Stem Cells as Potential Treatments for Osteoarthritis. Cells. 2021;10(6):1287.
[5] QU Y, WANG Y, WANG S, et al. A comprehensive analysis of single-cell RNA transcriptome reveals unique SPP1+ chondrocytes in human osteoarthritis. Comput Biol Med. 2023;160:106926.
[6] GLYN-JONES S, PALMER AJ, AGRICOLA R, et al. Osteoarthritis. Lancet. 2015; 386(9991):376-387.
[7] MINNIG MCC, GOLIGHTLY YM, NELSON AE. Epidemiology of osteoarthritis: literature update 2022-2023. Curr Opin Rheumatol. 2024;36(2):108-112.
[8] TANG J, LIU T, WEN X, et al. Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis. Mol Med. 2021;27(1):5.
[9] HE Y, MAKARCZYK MJ, LIN H. Role of mitochondria in mediating chondrocyte response to mechanical stimuli. Life Sci. 2020;263:118602.
[10] LIN X, TSAO CT, KYOMOTO M, et al. Injectable Natural Polymer Hydrogels for Treatment of Knee Osteoarthritis. Adv Healthc Mater. 2022;11(9):e2101479.
[11] COSTA MC, ANGELINI C, FRANZESE M, et al. Identification of therapeutic targets in osteoarthritis by combining heterogeneous transcriptional datasets, drug-induced expression profiles, and known drug-target interactions. J Transl Med. 2024;22(1):281.
[12] BOER CG. Osteoarthritis year in review 2024: Genetics, genomics, and epigenetics. Osteoarthritis Cartilage. 2025;33(1):50-57.
[13] FU W, WANG J, LI T, et al. Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload. Nat Chem Biol. 2025;21(8):1238-1249.
[14] HE F, MA Y, LI S, et al. Necroptotic TNFα-Syndecan 4-TNFα Vicious Cycle as a Therapeutic Target for Preventing Temporomandibular Joint Osteoarthritis. J Bone Miner Res. 2022;37(5):1044-1055.
[15] YIN Z, LI G, ZHONG Q, et al. Cinobufagin overcomes bortezomib resistance in multiple myeloma strains by targeting SEC62/TRPM4-mediated NECSO. Phytomedicine. 2025;147:157171.
[16] PROFF A, NAZET U, SCHRÖDER A, et al. Mechanical Stress Induces Sodium Entry and Osmoprotective Responses in Murine Synovial Fibroblasts. Cells. 2024;13(6):496.
[17] ULSHÖFER R, BROS H, HAUSER AE, et al. Preventing Axonal Sodium Overload or Mitochondrial Calcium Uptake Protects Axonal Mitochondria from Oxidative Stress-Induced Alterations. Oxid Med Cell Longev. 2022;2022:6125711.
[18] WIRTH KJ, SCHEIBENBOGEN C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). J Transl Med. 2021;19(1):162.
[19] QUINN TP, HESS JL, MARSHE VS, et al. A primer on the use of machine learning to distil knowledge from data in biological psychiatry. Mol Psychiatry. 2024; 29(2):387-401.
[20] SOUSA RT, SILVA S, PESQUITA C. Explaining protein-protein interactions with knowledge graph-based semantic similarity. Comput Biol Med. 2024;170:108076.
[21] CHO H, SHE J, DE MARCHI D, et al. Machine Learning and Health Science Research: Tutorial. J Med Internet Res. 2024;26:e50890.
[22] YI HC, YOU ZH, HUANG DS, et al. Graph representation learning in bioinformatics: trends, methods and applications. Brief Bioinform. 2022;23(1):bbab340.
[23] HUANG K, XIAO C, GLASS LM, et al. Machine learning applications for therapeutic tasks with genomics data. Patterns (N Y). 2021;2(10):100328.
[24] ZHANG C, XU L, MIAO X, et al. Machine learning assisted dual-modal SERS detection for circulating tumor cells. Biosens Bioelectron. 2025;268:116897.
[25] TAMINAU J, MEGANCK S, LAZAR C, et al. Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages. BMC Bioinformatics. 2012;13:335.
[26] LAN Z, YANG Y, SUN R, et al. A novel signature of cartilage aging-related immunophenotyping biomarkers in osteoarthritis. Comput Biol Med. 2025;187: 109816.
[27] ARBEEVA L, MINNIG MC, YATES KA, et al. Machine Learning Approaches to the Prediction of Osteoarthritis Phenotypes and Outcomes. Curr Rheumatol Rep. 2023;25(11):213-225.
[28] LIU G, HE G, ZHANG J, et al. Identification of SCRG1 as a Potential Therapeutic Target for Human Synovial Inflammation. Front Immunol. 2022;13:893301.
[29] WU CY, HSIEH HL, SUN CC, et al. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes. Glia. 2009; 57(16):1775-1789.
[30] NAGAOKA I, TAMURA H, REICH J. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model. Int J Mol Sci. 2020; 21(17):5973.
[31] WANG G, LI Y, YANG G, et al. Cathelicidin antimicrobial peptide (CAMP) gene promoter methylation induces chondrocyte apoptosis. Hum Genomics. 2021;15(1):24.
[32] HÖPFINGER A, SCHMID A, SCHWEITZER L, et al. Regulation of Cathelicidin Antimicrobial Peptide (CAMP) Gene Expression by TNFα and cfDNA in Adipocytes. Int J Mol Sci. 2023;24(21):15820.
[33] XUE Y, CHEN H, ZHANG S, et al. Resveratrol Confers Vascular Protection by Suppressing TLR4/Syk/NLRP3 Signaling in Oxidized Low-Density Lipoprotein-Activated Platelets. Oxid Med Cell Longev. 2021;2021:8819231.
[34] XUE H, ZHOU H, LOU Q, et al. Urolithin B reduces cartilage degeneration and alleviates osteoarthritis by inhibiting inflammation. Food Funct. 2024;15(7):3552-3565.
[35] TIMUR UT, JAHR H, ANDERSON J, et al. Identification of tissue-dependent proteins in knee OA synovial fluid. Osteoarthritis Cartilage. 2021;29(1):124-133.
[36] VAN LENT PL, GREVERS LC, BLOM AB, et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum. 2008;58(12):3776-3787.
[37] ZHONG ZX, ZHOU S, LIANG YJ, et al. Natural flavonoids disrupt bacterial iron homeostasis to potentiate colistin efficacy. Sci Adv. 2023;9(23):eadg4205.
[38] LIU M, LU J, CHEN Y, et al. Sodium Sulfite-Induced Mast Cell Pyroptosis and Degranulation. J Agric Food Chem. 2021;69(27):7755-7764.
[39] PITZER A, ELIJOVICH F, LAFFER CL, et al. DC ENaC-Dependent Inflammasome Activation Contributes to Salt-Sensitive Hypertension. Circ Res. 2022;131(4):328-344.
[40] MOURMOURA E, PAPATHANASIOU I, TRACHANA V, et al. Leptin-depended NLRP3 inflammasome activation in osteoarthritic chondrocytes is mediated by ROS. Mech Ageing Dev. 2022;208:111730.
[41] CHEN H, YE Z, KORPERSHOEK JV, et al. Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers. Mol Ther Nucleic Acids. 2025;36(2):102552.
[42] GOVINDARAJ K, METELING M, VAN ROOIJ J, et al. Osmolarity-Induced Altered Intracellular Molecular Crowding Drives Osteoarthritis Pathology. Adv Sci (Weinh). 2024;11(11):e2306722.
[43] ZHOU K, YANG C, SHI K, et al. Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage. Biomaterials. 2023;295:122036.
[44] PENG G, LI W, PENG L, et al. Multifunctional DNA-Based Hydrogel Promotes Diabetic Alveolar Bone Defect Reconstruction. Small. 2024;20(10):e2305594.
[45] TONG MJ, SONG MX, LIU Z, et al. A Bionic Thermosensitive Sustainable Delivery System for Reversing the Progression of Osteoarthritis by Remodeling the Joint Homeostasis. Adv Healthc Mater. 2024;13(16):e2303792.
[46] NAZIR MM, FARZEEN I, SAEED S, et al. Kaempferol as a multi-targeted phytotherapeutic for arthritis: systematic review and meta-analysis of preclinical models. Inflammopharmacology. 2025;33(7):3519-3542.
[47] HALLAND N, SCHMIDT F, WEISS T, et al. Rational Design of Highly Potent, Selective, and Bioavailable SGK1 Protein Kinase Inhibitors for the Treatment of Osteoarthritis. J Med Chem. 2022;65(2):1567-1584.
[48] GAO X, MA Y, ZHANG G, et al. Targeted elimination of intracellular reactive oxygen species using nanoparticle-like chitosan- superoxide dismutase conjugate for treatment of monoiodoacetate-induced osteoarthritis. Int J Pharm. 2020; 590:119947.
[49] ROLIG AS, ROSE DC, MCGEE GH, et al. Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8+ T cell cytotoxicity over BEMPEG+RT. J Immunother Cancer. 2022;10(4):e004218.
[50] ZHENG L, GU M, LI X, et al. ITGA5+ synovial fibroblasts orchestrate proinflammatory niche formation by remodelling the local immune microenvironment in rheumatoid arthritis. Ann Rheum Dis. 2025b;84(2):232-252.
|